Ketamine Clinical Trials
58 recruitingDrug
Phase 221Phase 414Phase 111Not Applicable5Phase 35Early Phase 13
Showing 1–20 of 58 trials
Recruiting
Early Phase 1
Ketamine and Propofol NeuroImaging
PainAnesthesia
Keith M Vogt60 enrolled1 locationNCT07294092
Recruiting
Phase 4
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Hemorrhoids
University of Oklahoma100 enrolled1 locationNCT04248205
Recruiting
Phase 4
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
Opioid UsePostoperative PainDepression+1 more
Texas Tech University Health Sciences Center90 enrolled2 locationsNCT06903819
Recruiting
Phase 2
Ketamine for Veterans With Parkinson's Disease
Parkinson's Disease
VA Office of Research and Development80 enrolled1 locationNCT06231563
Recruiting
Not Applicable
ACT_for Alcohol Use Disorder and Depression
Depression - Major Depressive DisorderAlcohol Use Disorder
Centre hospitalier de l'Université de Montréal (CHUM)30 enrolled1 locationNCT06620276
Recruiting
University of Iowa Interventional Psychiatry Service Patient Registry
Major Depressive DisorderMajor DepressionObsessive-Compulsive Disorder+4 more
Mark Niciu1,000 enrolled1 locationNCT04480918
Recruiting
Phase 1
Investigation of Psychedelic Effects in Psychoactive Substances
Psychedelic Effects in Healthy Volunteers
Johns Hopkins University50 enrolled1 locationNCT06772753
Recruiting
Anesthetics and Analgesics in Children
PainAnesthesia
Chi Dang Hornik460 enrolled13 locationsNCT03427736
Recruiting
Phase 3
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Chronic Daily Headache
University Health Network, Toronto56 enrolled2 locationsNCT05306899
Recruiting
Phase 1
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
HealthyMajor Depressive DisorderTreatment Resistant Depression
Baylor College of Medicine100 enrolled2 locationsNCT06480201
Recruiting
Phase 1
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
DepressionHealthy VolunteerMajor Depressive Disorder
National Institute of Mental Health (NIMH)150 enrolled1 locationNCT03065335
Recruiting
Early Phase 1
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Pancreatic CancerAnxiety
Cedars-Sinai Medical Center20 enrolled1 locationNCT05086250
Recruiting
Phase 1Phase 2
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Pain, Neuropathic
Rush University Medical Center25 enrolled1 locationNCT05864053
Recruiting
Phase 4
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
Major Depressive Disorder
Massachusetts General Hospital100 enrolled1 locationNCT05450432
Recruiting
Phase 2
Ketamine for Multiple Sclerosis Fatigue
Multiple Sclerosis Fatigue
Johns Hopkins University110 enrolled1 locationNCT05378100
Recruiting
Phase 2
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
AlcoholismAlcohol Use Disorder (AUD)Alcohol Abuse/Dependence
Dr. med. Marcus Herdener75 enrolled1 locationNCT06969937
Recruiting
Phase 2
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Alcohol Use DisorderAlcohol DependenceAlcohol Abuse
University of Iowa80 enrolled1 locationNCT06405607
Recruiting
Phase 2
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Demoralization
Charles S. Grob, M.D.100 enrolled5 locationsNCT05403086
Recruiting
Phase 2
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
Postoperative PainThoracoabdominal Aortic AneurysmDescending Aortic Dissection
Sam Tyagi30 enrolled1 locationNCT04600089
Recruiting
Phase 2
Intravenous Ketamine for Treatment-Resistant Depression
Treatment Resistant Depression (TRD)Depressive Disorder, Treatment-Resistant
Mayo Clinic30 enrolled1 locationNCT06668571